BridgeMD
New treatment option for Hypertension
Official title Effects of Combined High Intensity Interval Training and Resistance Training
ClinicalTrials.gov ID: NCT06845436
What this study is testing
- What it's testing
- Background: Hypertension has long been considered as a major risk factor for cardiovascular disease representing a high public health concern. Objectives: the purpose of this study is to evaluate the effects of combined HIIT and resistance training on body composition, blood pressure, and cardiorespiratory fitness in obese hypertensive men.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 60, men only
You may be able to join if
- men aged between 40 and 60 years old,
- have been diagnosed with clinical stage 1 or 2 hypertension,
- being obese with body mass index more than 30 kg/m2
- physically inactive
You likely can't join if
- musculoskeletal problems that may limit their ability to participate in resistance or HIIT programs
- diabetes mellitus
- a history of respiratory or chronic heart disease
The study team makes the final eligibility decision.
Where it's taking place
- Riyadh, Alkharj, Saudi Arabia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 40 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Riyadh, Alkharj, Saudi Arabia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.